Sun Pharmaceutical Industries Limited

Pulse data unavailable; neutral placeholder

Pulse tracks recent momentum in price, analyst revisions, and news sentiment. Higher means stronger near-term tailwinds.

Piotroski 9/9, ROCE 18.9%

Quality captures profitability, return on capital, and earnings consistency. Higher means a better business.

Wide moat

Moat estimates durable competitive advantages — brand, scale, switching costs. Higher means more defensible.

D/E 0.07, Int cov 60.4x

Safety looks at balance-sheet strength, leverage, and cash generation. Higher means lower financial risk.

Rev CAGR 10.6%

Growth reflects revenue and earnings expansion over recent years. Higher means faster compounding.

MoS 12%

Value measures whether the stock is cheap relative to its intrinsic worth. Higher is cheaper.